BIOMAT Database Logo BIOMAT Database Logo

[Recent data on the mechanism of action of the low molecular weight heparin fraction CY 216]. 1986

H Riederer, and K Breddin

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

H Riederer, and K Breddin
[Prophylactic and therapeutic use of a low molecular weight heparin fraction, CY 216].
January 1987, Journal des maladies vasculaires,
H Riederer, and K Breddin
In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
July 1985, Seminars in thrombosis and hemostasis,
H Riederer, and K Breddin
Pharmacological studies on the low molecular weight heparin derivative CY 216.
July 1990, Die Pharmazie,
H Riederer, and K Breddin
The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits.
June 1987, Thrombosis research,
H Riederer, and K Breddin
Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
January 1992, Nephron,
H Riederer, and K Breddin
Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (CY 216) in rabbits.
September 1986, Thrombosis research,
H Riederer, and K Breddin
[Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].
October 1986, Medizinische Klinik (Munich, Germany : 1983). Supplement,
H Riederer, and K Breddin
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).
July 1985, Seminars in thrombosis and hemostasis,
H Riederer, and K Breddin
[In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
January 1986, Annales pharmaceutiques francaises,
H Riederer, and K Breddin
Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
November 1986, Thrombosis research,
Copied contents to your clipboard!